The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy of local versus systemic salvage therapies for recurrent prostate cancer after primary radiotherapy.
 
Glenn Bauman
No Relationships to Disclose
 
Keyue Ding
No Relationships to Disclose
 
Joseph Chin
Consulting or Advisory Role - Profound Medical
Research Funding - Profound Medical
Travel, Accommodations, Expenses - Ferring, Profound Medical, Amgen Canada
 
Alessandra Iaboni
No Relationships to Disclose
 
Laurence Klotz
Leadership - miR Scientific
Honoraria - Amgen; Bayer; Exact imaging; Ferring; Profound Medical; Sanofi
Research Funding - Exact Imaging; Ferring
Expert Testimony - Profound Medical
Travel, Accommodations, Expenses - TerSera
 
David P. Dearnaley
Honoraria - Janssen; Sandoz; Takeda
Consulting or Advisory Role - Cadence Research and Consulting; FirstWord; Janssen; Janssen Research & Development; Sandoz; Takeda
Speakers' Bureau - Janssen; Janssen-Cilag
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst); Patent issued EP1933709B1 (location and stabilisation device)
Expert Testimony - Vitality Life
Travel, Accommodations, Expenses - Janssen; Takeda
 
Eric M. Horwitz
No Relationships to Disclose
 
Juanita M. Crook
Honoraria - Abbvie; Tersera
Consulting or Advisory Role - Concure Oncology Breast Microseed
 
Christopher J. O'Callaghan
No Relationships to Disclose